References
- Taylor, D D.; Bender, D P.; Gercel-Taylor, C.; Stanson, J.; Whiteside, T L. Modulation of TCR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients.Br. J. Cancer 2001, 84 (12), 1624–1629. [PUBMED], [INFOTRIEVE], [CSA]
- Botti, C.; Seregni, E.; Ferrari, L.; Martinetti, A.; Bombardieri, E. Immunosuppressive factors: role in cancer development and progression.Int. J. Biol. Markers 1998, 13 (2), 51–69., [PUBMED], [INFOTRIEVE], [CSA]
- Mckallip, R.; Li, R.; Ladisch, S. Tumor gangliosides inhibit the tumor-specific immune response.J. Immunol. 1999, 163 (7), 3718–3726. [PUBMED], [INFOTRIEVE], [CSA]
- Piccirillo, C A.; Shevah, E M. Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.J. Immunol. 2001, 167 (3), 1137–1140. [PUBMED], [INFOTRIEVE], [CSA]
- Sakaguchi, S.; Sakaguchi, N.; Asano, M.; Itoh, M.; Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of single mechanism of self-tolerance causes various autoimmune diseases.J. Immunol. 1995, 155 (3), 1151–1164. [PUBMED], [INFOTRIEVE], [CSA]
- Thornton, A M.; Shevach, E M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.J. Exp. Med. 1998, 188 (2), 287–296. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Levings, M K.; Sangregorio, R.; Roncarolo, M G. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.J. Exp. Med. 2001, 193 (11), 1295–1301. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sutmuller, R P.; van-Duivenvoorde, L M.; van-Elsas, A.; Schumacher, T N.; Wildenberg, M E.; , et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.J. Exp. Med. 2001, 194 (6), 823–832. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shimizu, J.; Yamazak, S.; Sakaguchi, S. Induction of tumor immunity by removing CD25+CD4+T cells: a common basis between tumor immunity and autoimmunity.J. Immunol. 1999, 163 (10), 5211–5218. [PUBMED], [INFOTRIEVE], [CSA]
- Steitz, J.; Bruck, J.; Lenz, J.; Knop, J.; Tuting, T. Depletion of CD25+CD4+ T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon α-induced CD8+ T cell dependent immune defense of B 16 melanoma.Cancer Res. 2001, 61 (24), 8643–8646. [PUBMED], [INFOTRIEVE], [CSA]
- Seo, N.; Hayakawa, S.; Takigawa, M.; Tokura, Y. Interleukin-10 expressed at early tumor sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity.Immunology 2001, 103 (4), 449–457. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Woo, E Y.; Chu, C S.; Golez, T J.; Schlienger, K.; Yeh, H.; , et al. Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.Cancer Res. 2001, 61 (12), 4766–4772. [PUBMED], [INFOTRIEVE], [CSA]
- Woo, E Y.; Yeh, H.; Chu, C S.; Schlienger, K.; Carroll, R G. Regulatory T cells from llung cancer patients directly inhibit autologous T cell proliferation.J. Immunol. 2002, 168 (9), 4272–4276. [PUBMED], [INFOTRIEVE], [CSA]
- Wolf, A M.; Wolf, D.; Steurer, M.; Gastl, G.; Gunsilius, E.; Grubeck-Loebenstein, B. Increase of regulatory T cells in the peripheral blood of cancer patients.Clin. Cancer Res. 2003, 9 (2), 606–612. [PUBMED], [INFOTRIEVE], [CSA]
- Liyanage, U K.; Moore, T T.; Joo, H G.; Tanaka, Y.; Herrmann, V. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.J. Immunol. 2002, 169 (5), 2756–2761. [PUBMED], [INFOTRIEVE], [CSA]